Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders

Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders

Saved in:

Bibliographic Details
Main Authors:	Saad Z. Usmani, Nilanjan Ghosh, Peter Voorhees, Edward Copelan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Subjects:	hematopoietic cell transplantation CAR T cells lymphomas multiple myeloma cellular therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1527836/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.
by: Daniele Avenoso, et al.
Published: (2023-06-01)

High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma—Is There Still a Role?
by: Michael Daunov, et al.
Published: (2024-10-01)

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
by: Kaili Chen, et al.
Published: (2025-01-01)

COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center.
by: Afadil Adam
Published: (2020-08-01)

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant
by: Richard LeBlanc, et al.
Published: (2024-11-01)

Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantation
by: Yanhua Yue, et al.
Published: (2025-12-01)

Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma
by: Gi-June Min, et al.
Published: (2024-11-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
by: Giuseppe Visani, et al.
Published: (2012-11-01)

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study
by: Cristian Maximiliano Seehaus, et al.
Published: (2024-12-01)

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma
by: Xiaodan Luo, et al.
Published: (2024-12-01)

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
by: Ugo Testa, et al.
Published: (2024-10-01)

Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China
by: Xuelin Dou, et al.
Published: (2025-01-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HEMATOLOGICAL MALIGNANCIES
by: Gokhan Sargin, et al.
Published: (2014-08-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study)
by: Annemarie Glöckner, et al.
Published: (2025-01-01)

Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy
by: Gianluca Cavallaro
Published: (2024-04-01)

CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Rafael de la Camara
Published: (2016-06-01)

LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01)

Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series
by: Alice Mariottini, et al.
Published: (2024-11-01)

PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Isidro Jarque, et al.
Published: (2016-07-01)

Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma
by: Tong‐Yoon Kim, et al.
Published: (2025-01-01)

Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment
by: Min Ji Jeon, et al.
Published: (2024-11-01)

Advances in hematopoietic stem cell transplantation for autoimmune diseases
by: Yuxi Xu, et al.
Published: (2024-10-01)

Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
by: Diego Medina, et al.
Published: (2024-12-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Infectious Causes of Early Mortality After Hematopoietic Stem Cell Transplantation
by: Pelin İrkören, et al.
Published: (2024-12-01)

Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma
by: Hui-Ju Hsieh, et al.
Published: (2025-03-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Gianluca Gaidano, et al.
Published: (2009-11-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Daniela Capello, et al.
Published: (2009-11-01)

Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation
by: Ekaterina Pashkina, et al.
Published: (2024-12-01)

Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
by: María Queralt Salas, et al.
Published: (2024-12-01)

CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
by: Ugo Testa, et al.
Published: (2023-10-01)

Modified screening and management strategies for chronic rhinosinusitis in hematologic patients receiving hematopoietic stem cell transplantation
by: Yen-Hui Lee, et al.
Published: (2025-02-01)

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
by: Ka-Won Kang, et al.
Published: (2025-02-01)

Primary cutaneous gamma–delta T cell lymphoma presenting as a leg ulcer in a kidney transplant recipient on hemodialysis: a case report with a literature review
by: Yuki Oba, et al.
Published: (2025-01-01)

Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
by: Gianmarco Bagnato, et al.
Published: (2024-01-01)

Resolution of hypogammaglobulinemia-associated recurrent Campylobacter bacteraemia after hematopoietic cell transplantation (HCT)
by: Emmanouil Karofylakis, MD, et al.
Published: (2025-02-01)

Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement
by: Guido Lancman, et al.
Published: (2024-11-01)